Biopharmaceuticals Manufacturing Consumables Testing Market Report, 2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Biopharmaceuticals Manufacturing Consumables Testing Market


The global Biopharmaceuticals Manufacturing Consumables Testing market size is projected to reach US$ 796.14 million by 2026, from US$ 401.2 million in 2020, at a CAGR of 12.1% during 2021-2026. Successful and efficient biopharmaceutical manufacturing is largely dependent on the purity and quality of consumables used during production. With growing issues pertaining to quality of novel therapeutics such as poor solubility, increase in molecular sizes, and poor absorption properties, there is a rise in focus on exploring the various attributes of excipients and other raw materials.

Establishing identity, purity, and quality of raw/starting material is a crucial step in biopharmaceutical manufacturing. This is because any variation in excipient, additives, or API profile with respect to impurity, particle size, dissolution characteristics, and other factors can drastically influence the functioning and performance of the final product.

Quality standards have gradually evolved to support biologics production. Constant improvement in regulatory standards for biologic production also encompasses use of proper raw materials and their qualification assessment. Regulations and guidance standards with respect to region-specific pharmacopeia have also accelerated raw material investigation to meet the requirements of biopharma manufacturers.

Characterization of raw materials by vendors in co-operation and collaboration with players in the pharma and biopharmaceutical industry helps address issues associated with the manufacturing process, thereby facilitating rapid launch of the final product in the market. These issues include quality-by-design and bioavailability of products.

Perpetual introduction of new technologies and advancements in existing technologies for efficient large molecule production is one of the key drivers of this market. While some advancements are solely focused on biopharmaceutical production, the industry is also witnessing technological innovations to support thorough quality check based processing, right from raw materials to finished drugs.

Technological advancements in analytical technologies have provided vendors with improved capabilities to test proteins, raw materials, cell lines, and other consumables used during the production of large molecules. Advancements in portable Raman spectroscopy methods is one of the significant developments in this market. Agilent Technologies is one of the companies offering products based on the principle of Raman spectroscopy.

Market Segmentation, Outlook & Viewpoint: Global Biopharmaceuticals Manufacturing Consumables Testing Market

Service Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Laboratory Testing

  
Chemical Analysis Testing
  
Enzyme Testing
  
Stability Testing
  
Sterility Testing
  
Others

Custom Testing / Customer Proprietary Testing

Compendial & Multi Compendial Laboratory Testing

Raw Material Type Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Formulation Excipients
  
Active Pharmaceutical Ingredients (API)
  
Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support

Key Players, Recent Developments & Regional Insights: Global Biopharmaceuticals Manufacturing Consumables Testing Market

By raw material, the biopharmaceuticals manufacturing consumables testing market is segmented into formulation excipients, Active Pharmaceutical Ingredients (API), and compendial methods (EP / JP / USP) based vendor qualification program support. API investigation services accounted for the largest revenue share in 2017 whereas compendial methods-based vendor qualification program support is anticipated to grow at a lucrative pace in the coming years.
API assessment is a routine testing process in biopharma manufacturing. However, API characterization for biologic molecules is relatively more difficult and time-consuming as compared to synthetic APIs.

Rapid growth of the biopharma industry has made it necessary to keep pace with changing or improving regulatory requirements for analysis of raw materials required during biologics manufacturing. As a result, final product manufacturers seek vendor qualification program support to validate if services offered by the vendor comply with compendial monographs. This has driven the segment for compendial methods-based vendor qualification program support.

Regional Insights

North America dominated the market in 2017 with respect to revenue owing to presence of substantial number of biopharmaceutical manufacturing facilities in U.S. Furthermore, effective regulations pertaining to biopharmaceutical production and approval in the country has contributed to the large share of North America in the global market.

Asian countries, with China and India at the forefront, are expected to emerge as lucrative sources of revenue in the coming years. This is due to improving biopharmaceutical industry in the region as well as shift in attention of international companies toward the Asian market for outsourcing options.
Biopharmaceuticals Manufacturing Consumables Testing Market Share Insights

Alcami Corporation; Merck KGaA; Eurofins Scientific; Agilent Technologies; Charles River; Catalent, Inc.; Avomeen Analytical Services; BioSpectra; and Pace Analytical Services, LLC are some service providers engaged in providing services for consumables testing in the biopharmaceutical industry. Other key participants include Gibraltar Laboratories; Pacific BioLabs; Toxikon, Inc.; Activation Laboratories Ltd.; MabPlex Inc.; SGS SA; Pharmetric Laboratory; Albany Molecular Research Inc.; Avance Biosciences; Triclinic Labs; Lonza; Boston Analytical; and STERIS.

These service providers are engaged in strategic alliances with several prominent biopharmaceutical companies across the globe. They are making focused attempts to meet changing regulatory requirements and fulfilling rising demand.

Key Insights Covered: Global Biopharmaceuticals Manufacturing Consumables Testing Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Biopharmaceuticals Manufacturing Consumables Testing industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Biopharmaceuticals Manufacturing Consumables Testing industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Biopharmaceuticals Manufacturing Consumables Testing industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Biopharmaceuticals Manufacturing Consumables Testing industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Biopharmaceuticals Manufacturing Consumables Testing industry.

Research Methodology: Global Biopharmaceuticals Manufacturing Consumables Testing Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other